For the quarter ending 2025-09-30, FBRX made $19,084K in revenue. -$17,682K in net income. Net profit margin of -92.65%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 15,050 | 8,469 | ||
| Research and development - related party | 150 | 150 | ||
| General and administrative | 3,183 | 2,960 | ||
| Total operating expenses | 18,383 | 11,579 | ||
| Loss from operations | -18,383 | -11,579 | ||
| Other income, net | 701 | 330 | ||
| Net loss | -17,682 | -11,249 | ||
| Net loss per share - basic | -0.99 | -0.96 | ||
| Net loss per share - diluted | -0.99 | -0.96 | ||
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)